Pure filamentous bacteriophage and methods of producing same
AssigneeNeuroPhage Pharmaceuticals, Inc.
InventorsJason Wright, Antony Hitchcock, Frank Sugar, Tim Davies, Shreekant Adhikari, Nanda Menon, Quentin Florence
Life of this patent
Estimating the term…
Abstract
The invention relates to compositions of purified filamentous bacteriophage, as well as methods that allow reproducible purification of high concentrations of filamentous bacteriophage.
Claims20
A pharmaceutical composition comprising wild-type filamentous bacteriophage or filamentous bacteriophage which does not display an antibody or a non-filamentous bacteriophage antigen on its surface, said composition comprising less than 1×10−10 endotoxin units per filamentous bacteriophage;
- and a pharmaceutically acceptable carrier.
A method of reducing the amount of amyloid plaque in a patient suffering from a plaque-forming disease, comprising the step of administering to the patient a pharmaceutical composition comprising filamentous bacteriophage;
- and a pharmaceutically acceptable carrier, wherein the composition comprises less than 1×10−10 endotoxin units per filamentous bacteriophage.
Dependencies are inferred from the claim text.